Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus

Publisher： Karger

E-ISSN： 1423-0143|34|4|209-217

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.34, Iss.4, 2011-06, pp. : 209-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal AA Amyloidosis in Patients with Type 2 Diabetes Mellitus

By  

Nephron Extra, Vol. 4, Iss. 2, 2014-07 ,pp. : 119-126

Karger

Access to resources Recommend Favorite

Prevalence of Nephropathy in Black Patients with Type 2 Diabetes mellitus

By  

American Journal of Nephrology, Vol. 22, Iss. 1, 2002-03 ,pp. : 35-41

Karger

Access to resources Recommend Favorite

Effect of Cerivastatin on Urinary Albumin Excretion and Plasma Endothelin-1 Concentrations in Type 2 Diabetes Patients with Microalbuminuria and Dyslipidemia

By  

American Journal of Nephrology, Vol. 21, Iss. 6, 2001-12 ,pp. : 449-454

Karger

Access to resources Recommend Favorite

Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-05 ,pp. : 104-114

Karger

Access to resources Recommend Favorite

Association between Glycosylated Haemoglobin Level and Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus

By  

Cardiorenal Medicine, Vol. 4, Iss. 2, 2014-05 ,pp. : 95-102

Karger

Access to resources Recommend Favorite